Showing 2941-2950 of 3223 results for "".
- Roche Begins Shipments of First 400,000 COVID-19 Tests to Laboratories Across UShttps://modernod.com/news/roche-begins-shipments-of-first-400000-covid-19-tests-to-laboratories-across-us/2477397/Roche announced that it has begun shipping the first allotment of its cobas SARS-CoV-2 Test for COVID-19 (coronavirus) to a network of hospital and reference laboratories across the U.S. to enable automated, high-volume patient testing. Shipping of the initial 400,000 test kits began
- Nicox Updates on Zerviate Progress in China and Expands the Countries of its Agreement with Ocumension Therapeuticshttps://modernod.com/news/nicox-updates-on-zerviate-progress-in-china-and-expands-the-countries-of-its-agreement-with-ocumension-therapeutics/2477370/Nicox SA announced that it has amended its March 2019 license agreement with Ocumension Therapeutics granting Ocumension exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of allergic conjunctivitis in
- Geuder Appoints Head of Innovation and Strategyhttps://modernod.com/news/geuder-appoints-head-of-innovation-and-strategy/2477355/Julius Müller-Albinus has joined Geuder as Head of Innovation Management and Strategy as of January 13, 2020. Mr. Müller-Albinus is responsible for the company-wide innovation management. Mr. Müller-Albinus will be responsible for establishing sustainable innovation processes, realizing managemen
- Companies in US Drug Supply Chain Unveil Pilot Project to Track Counterfeit Medicineshttps://modernod.com/news/companies-in-us-drug-supply-chain-unveil-pilot-project-to-track-counterfeit-medicines/2477315/Several companies, including Pfizer, GlaxoSmithKline, Roche, Eli Lilly, Novartis, Sanofi, Novo Nordisk, Amgen and Gilead Sciences, have created a blockchain-based platform to track prescription products across the supply chain in an effort to better stem the flow of counterfeit medicines, a
- Iscalimab Promising for Sjogren’s Syndromehttps://modernod.com/news/iscalimab-promising-for-sjogrens-syndrome/2477313/The anti-CD40 monoclonal antibody iscalimab showed preliminary efficacy against Sjogren’s syndrome in a proof-of-concept study, according to a Reuters report. Although Sjogren’s syndrome is a relatively common condition
- Could a Hormone be Used to Treat Eye Disease?https://modernod.com/news/could-a-hormone-be-used-to-treat-eye-disease/2477314/John A. Moran Eye Center researchers continue to shed new light on the potential of the hormone erythropoietin (EPO) to treat eye disease. EPO increases red blood cell production, and is already used clinically to treat anemia. However, more recently EPO is being recognized for other properties,
- Myopia Management Focus of Pipeline Expansion for Leo Lens Pharmahttps://modernod.com/news/myopia-management-focus-of-pipeline-expansion-for-leo-lens-pharma/2477307/Leo Lens Pharma (formerly DBA as Leo Lens Technology Co.) announced it received a notice of allowance from the United States Patent and Trademark Office for a patent for the use of its proprietary MediPrint process to manufacture a contact lens capable of providing enhance
- Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Deviceshttps://modernod.com/news/santen-and-verily-establish-joint-venture-to-develop-and-commercialize-unique-ophthalmic-devices/2477285/Santen Pharmaceutical and Alphabet subsidiary Verily announced the establishment of a joint venture focused on applying microelectronics and scalable digital technologies to ophthalmology. The new joint venture is driven by a mission to improve eye health for people everywhere, starting by
- Calvin Roberts, MD, Named President and CEO of Lighthouse Guildhttps://modernod.com/news/calvin-roberts-md-named-president-and-ceo-of-lighthouse-guild/2477286/Calvin Roberts, MD, has been elected President and CEO of Lighthouse Guild. Dr. Roberts will leave his position as Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies, on March 31. Dr. Roberts i
- EyeTech Launches EyeOn Ultra-Compact Eye-Tracking Tablet Platformhttps://modernod.com/news/eyetech-launches-eyeon-ultra-compact-eye-tracking-tablet-platform/2477269/EyeTech Digital Systems announced the launch of EyeOn, an all-in-one, ultra-slim eye gaze tablet during this year’s Assistive Technology Industry Association conference in Orlando. The EyeOn eye tracking platform enables people with mobility and motor impairments to select, type, and speak entire